AR098592A1 - Formas cristalinas de 1-[4-(piridin-2-iloxi)-ciclohexil]-5,6-dihidro-4h-2,3,5,10b-tetraaza-benzo[e]azulenos - Google Patents

Formas cristalinas de 1-[4-(piridin-2-iloxi)-ciclohexil]-5,6-dihidro-4h-2,3,5,10b-tetraaza-benzo[e]azulenos

Info

Publication number
AR098592A1
AR098592A1 ARP140104488A ARP140104488A AR098592A1 AR 098592 A1 AR098592 A1 AR 098592A1 AR P140104488 A ARP140104488 A AR P140104488A AR P140104488 A ARP140104488 A AR P140104488A AR 098592 A1 AR098592 A1 AR 098592A1
Authority
AR
Argentina
Prior art keywords
ciclohexil
iloxi
piridin
dihidro
azulen
Prior art date
Application number
ARP140104488A
Other languages
English (en)
Spanish (es)
Inventor
Trussardi Ren
Dr Hoffmann-Emery Fabbienne
Dr Schwitter Urs
Dr Grassmann Olaf
Dr Hartung Thomas
Ran Frederic
Dr Diodone Ralph
Pfleger Christophe
Dr Bartels Bjrn
Dr Rothenhusler Benno
Dr Adam Jean-Michel
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of AR098592A1 publication Critical patent/AR098592A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/55131,4-Benzodiazepines, e.g. diazepam or clozapine
    • A61K31/55171,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
ARP140104488A 2013-12-05 2014-12-03 Formas cristalinas de 1-[4-(piridin-2-iloxi)-ciclohexil]-5,6-dihidro-4h-2,3,5,10b-tetraaza-benzo[e]azulenos AR098592A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP13195864 2013-12-05

Publications (1)

Publication Number Publication Date
AR098592A1 true AR098592A1 (es) 2016-06-01

Family

ID=49726573

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP140104488A AR098592A1 (es) 2013-12-05 2014-12-03 Formas cristalinas de 1-[4-(piridin-2-iloxi)-ciclohexil]-5,6-dihidro-4h-2,3,5,10b-tetraaza-benzo[e]azulenos

Country Status (19)

Country Link
US (3) US10246460B2 (https=)
EP (1) EP3077396B1 (https=)
JP (1) JP6454707B2 (https=)
KR (3) KR102384629B1 (https=)
CN (1) CN105793263B (https=)
AR (1) AR098592A1 (https=)
AU (2) AU2014359409A1 (https=)
CA (2) CA3142754C (https=)
ES (1) ES2875411T3 (https=)
HR (1) HRP20210966T1 (https=)
IL (2) IL245450A0 (https=)
MX (1) MX372971B (https=)
MY (1) MY175464A (https=)
NZ (1) NZ720340A (https=)
PL (1) PL3077396T3 (https=)
SG (1) SG11201604502SA (https=)
SI (1) SI3077396T1 (https=)
WO (1) WO2015082370A1 (https=)
ZA (1) ZA201603304B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6454707B2 (ja) 2013-12-05 2019-01-16 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft trans−8−クロロ−5−メチル−1−[4−(ピリジン−2−イルオキシ)−シクロヘキシル]−5,6−ジヒドロ−4H−2,3,5,10b−テトラアザ−ベンゾ[e]アズレン及びその結晶形態の合成
WO2017191117A1 (en) 2016-05-03 2017-11-09 Bayer Pharma Aktiengesellschaft V1a receptor antagonists for use in the treatment of renal diseases
BR112020004035A2 (pt) 2017-12-08 2020-09-01 F. Hoffmann-La Roche Ag formulação farmacêutica
WO2020139670A1 (en) 2018-12-27 2020-07-02 Teva Pharmaceuticals International Gmbh Solid state forms of balovaptan
WO2023059110A1 (ko) 2021-10-06 2023-04-13 주식회사 엘지에너지솔루션 배터리 모듈

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1197242A (en) * 1983-03-02 1985-11-26 Jean A. Gauthier Pyrimido¬1,2-a|pyrrolo¬2,1-c|¬1, 4|benzodiazepine-3-carboxylic acid derivatives
GB0303852D0 (en) 2003-02-19 2003-03-26 Pfizer Ltd Triazole compounds useful in therapy
KR100750028B1 (ko) * 2003-02-19 2007-08-16 화이자 인코포레이티드 치료에 유용한 트리아졸 화합물
GB0400700D0 (en) 2004-01-13 2004-02-18 Pfizer Ltd Compounds useful in therapy
CA2578370A1 (en) 2004-08-25 2006-03-02 Pfizer Inc. Triazolobenzodiazepines and their use as vasopressin antagonists
US7601715B2 (en) 2005-06-22 2009-10-13 Bristol-Myers Squibb Company Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein
RU2510397C2 (ru) * 2008-11-18 2014-03-27 Ф. Хоффманн-Ля Рош Аг Алкилциклогексиловые эфиры дигидротетраазабензоазуленов
BRPI0922303B1 (pt) 2008-11-28 2019-11-12 Hoffmann La Roche arilciclo-hexiléteres de di-hidrotetra-azabenzoazulenos, seu processo de preparação, composição farmacêutica que os compreende e uso
US8492376B2 (en) 2010-04-21 2013-07-23 Hoffmann-La Roche Inc. Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes
PE20160203A1 (es) 2013-08-19 2016-04-20 Hoffmann La Roche Antagonistas de via para tratar trastornos del sueno por cambio de fase
JP6454707B2 (ja) * 2013-12-05 2019-01-16 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft trans−8−クロロ−5−メチル−1−[4−(ピリジン−2−イルオキシ)−シクロヘキシル]−5,6−ジヒドロ−4H−2,3,5,10b−テトラアザ−ベンゾ[e]アズレン及びその結晶形態の合成

Also Published As

Publication number Publication date
ES2875411T3 (es) 2021-11-10
CA3142754C (en) 2024-01-02
CA2931016C (en) 2022-11-01
CN105793263A (zh) 2016-07-20
HK1223918A1 (zh) 2017-08-11
US20190194210A1 (en) 2019-06-27
ZA201603304B (en) 2022-05-25
JP6454707B2 (ja) 2019-01-16
KR102384629B1 (ko) 2022-04-11
CN105793263B (zh) 2019-08-23
US11040977B2 (en) 2021-06-22
AU2019201183A1 (en) 2019-03-14
JP2016539168A (ja) 2016-12-15
US20210284648A1 (en) 2021-09-16
KR102384630B1 (ko) 2022-04-11
IL245450A0 (en) 2016-06-30
AU2014359409A1 (en) 2016-05-19
CA3142754A1 (en) 2015-06-11
CA2931016A1 (en) 2015-06-11
WO2015082370A1 (en) 2015-06-11
US12459947B2 (en) 2025-11-04
KR20160093709A (ko) 2016-08-08
EP3077396B1 (en) 2021-04-21
RU2018135601A (ru) 2018-11-22
NZ759478A (en) 2021-06-25
US20160280712A1 (en) 2016-09-29
KR20210134985A (ko) 2021-11-11
HRP20210966T1 (hr) 2021-09-17
SG11201604502SA (en) 2016-07-28
IL264891B (en) 2021-02-28
US10246460B2 (en) 2019-04-02
PL3077396T3 (pl) 2021-10-04
RU2018135601A3 (https=) 2022-05-05
SI3077396T1 (sl) 2021-08-31
KR102384608B1 (ko) 2022-04-08
NZ720340A (en) 2020-03-27
AU2019201183B2 (en) 2021-03-04
MY175464A (en) 2020-06-29
MX2016006558A (es) 2016-08-03
KR20210132745A (ko) 2021-11-04
MX372971B (es) 2020-03-27
EP3077396A1 (en) 2016-10-12

Similar Documents

Publication Publication Date Title
IL281807B (en) Processes of making and crystalline forms of a mdm2 inhibitor
MX378288B (es) Inhibidores de pirimidina del fgfr4.
CR20150418A (es) Compuestos de tetrahidropirrolotiazina
CY1119105T1 (el) Παραγωγα διπυραζολιου ως αναστολεις jak
UY36480A (es) Uso de compuestos de picolinamida como fungicidas
CU24411B1 (es) Compuesto derivado de benzamida sustituida con 1,3-tiazol-2-ilo útil para el tratamiento de trastornos neurogénicos
UY36287A (es) COMPUESTO DE OBJETIVO A IL-23A y TNF-ALFA Y USO DEL MISMO
CR20210079A (es) Sulfamoilarilamidas y su uso como medicamentos para el tratamiento de la hepatitis b
AR112276A1 (es) Polimorfos de 5-fluoro-4-imino-3-metil-1-tosil-3,4-dihidropirimidin-2-ona
DOP2016000242A (es) Uso de compuestos heterocíclicos para controlar nematodos
PH12015501807A1 (en) Vortioxetine manufacturing process
CL2016001095A1 (es) Silicato de zirconio microporoso para el tratamiento de hipercalemia.
GT201500247A (es) Imidazopiridazinas sustituidas
AR095048A1 (es) Proceso electroquímico para el acoplamiento de fenol a anilina
CL2017001131A1 (es) Síntesis de copanlisib y su sal diclorhidrato
BR112017008481A2 (pt) composto antimicótico
CU20160003A7 (es) Pirazololpiridinaminas sustituidas
LT3552017T (lt) Junginiai, naudotini kaip ripk1 inhibitoriai
AR098592A1 (es) Formas cristalinas de 1-[4-(piridin-2-iloxi)-ciclohexil]-5,6-dihidro-4h-2,3,5,10b-tetraaza-benzo[e]azulenos
CL2015002358A1 (es) Compuestos bicíclicos.
EA201591915A1 (ru) Соединения феноксиэтил дигидро-1h-изохинолина
UY34902A (es) Forma cristalina de un derivado de indolinona y su uso
MX2016006977A (es) Proceso para la preparacion de 5-fluoro-1h-pirazoles.
MX2018007415A (es) Metodos para preparar 5,6-dihidro-6-fenilbenzo[f]isoquinolin-2-ami na sustituida.
BR112016027455A2 (pt) moduladores ppar

Legal Events

Date Code Title Description
FB Suspension of granting procedure